AD-227
/ Yuhan Corp
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 19, 2025
A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B
(clinicaltrials.gov)
- P1 | N=60 | Recruiting | Sponsor: Addpharma Inc.
New P1 trial • Cardiovascular • Hypertension
1 to 1
Of
1
Go to page
1